This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: University of Michigan, Other. Active years: 2022-2025.
Company Filing History:
1 out of 3,523 
1 out of 834,411 Years Active: 2022-2025
Title: Hyo Je Cho: Innovator in NSD Family Inhibitors
Introduction
Hyo Je Cho is a notable inventor located in Ann Arbor, MI, who has made significant contributions to the field of pharmaceutical innovations. With a total of two patents to his name, Cho focuses on developing treatments for various cancers, offering new hope for patients suffering from these diseases.
Latest Patents
Cho's latest patents center around NSD family inhibitors and methods of treatment associated with them. These patents detail small molecule inhibitors targeting the activity of NSD1, NSD2, and/or NSD3. The methods outlined in the patents highlight potential treatments for diseases such as leukemia, breast cancer, osteosarcoma, lung and prostate cancers, as well as other solid tumors and diseases reliant on the activity of these genes.
Career Highlights
Throughout his career, Hyo Je Cho has worked at several prestigious institutions, including the University of Michigan. His research has contributed to the growing body of knowledge in the fields of oncology and drug discovery, making him a key figure in the development of innovative cancer therapies.
Collaborations
Cho has collaborated with esteemed colleagues such as Tomasz Cierpicki and Jolanta Grembecka. Their joint efforts have helped advance the research and practical applications of NSD family inhibitors, enhancing their potential effectiveness in combating various forms of cancer.
Conclusion
Hyo Je Cho stands out as a prominent inventor dedicated to improving cancer treatment methodologies through his innovative research on NSD family inhibitors. His work continues to inspire and drive advancements in the medical field, potentially changing the lives of countless patients.